Skip directly to page options Skip directly to A-Z link

Volume 15, Number 11—November 2009

Dispatch

Fatal Case of Enterovirus 71 Infection, France, 2007

Sophie ValletComments to Author , Marie-Christine Legrand-Quillien, Thomas Dailland, Gaëtan Podeur, Stéphanie Gouriou, Isabelle Schuffenecker, Christopher Payan, and Pascale Marcorelles
Author affiliations: Université Européenne de Bretagne, Brest, France (S. Vallet, G. Podeur, S. Gouriou, C. Payan); Centre Hospitalier Universitaire, Brest (S. Vallet, M.-C. Legrand-Quillen, T. Dailland, C. Payan, P. Marcorelles); Centre de Biologie et Pathologie Est, Bron, France (I. Schuffenecker)

Main Article

Table

EV71 clinical strains used in phylogenetic analysis of the complete VP1 gene*

GenBank accession no. Year Origin Clinical features Isolate Genogroup Reference
U22521 1970 USA Encephalitis BrCr-CA-70 A (1)
AF135883 1974 Australia Meningitis 2604-AUS-74 B1 (1)
AF135870 1977 USA NA 2231-NY-77 B1 (1)
AF009533 1987 USA Gastroenteritis 7631-PA-87 B2 (1)
AF009540 1988 USA Fever 2222-IA-88 B2 (1)
AF376117 1998 Singapore HFMD 3799/SIN/98 B3 (2)
AF376095 1999 Australia HFMD 18F/AUS/6/99 B3 (2)
AF376084 2000 Sarawak HFMD S21082/SAR/2000 B4 (2)
AF376111 2000 Singapore NA 2027/SIN/2001 B4 (2)
AF376121 2000 Singapore HFMD 5511/SIN/2000 B5 (2)
FM201341 2006 Brunei NA BRU/2006/35247 B5 (5)
AF376087 2000 Sarawak HFMD S40221/SAR/2000 C1 (2)
DQ452074 2003 Norway NA 804/NO/2003 C1 (10)
AM939598 2005 UK Unspecified neurologic disease HO-5400-288-05 C1 (8)
AF135950 1998 Missouri Meningitis 2814-MO-98 C2 (1)
AF136379 1998 Taiwan Death NCKU9822 C2 (3)
AM939583 1999 UK Aseptic meningitis EP/5622/99 C2 (8)
AF376108 1999 Australia Meningitis 7F/AUS/6/99 C2 (2)
AF376102 1999 Australia HFMD 27M/AUS/2/99 C2 (2)
AF376110 1999 Australia Ataxia 9F/AUS/6/99 C2 (2)
AY208099 2001 France Guillain-Barré syndrome W1244-50/2001 C2 (11)
AM939604 2006 UK Meningitis HO-6332-439-06 C2 (8)
AM939607 2006 UK Irritable, rash HO-6364-255-06 C2 (8)
AM939597 2006 UK Panencephalitis, fatal STH/MCN/06 C2 (8)
AM939599 2006 UK Difficulty walking HO-6486-445-06 C2 (8)
FJ461786 2008 Singapore NA NUH0013/SIN/2008 C2 UD
FJ151492 2007 Thailand NA THA-07-01647 C2 UD
FJ525952 2008 Edinburgh NA CSF-2431/2008 C2 (9)
AY125966 2001 Korea NA KOR-EV71-01 C3 UD
AY125967 2002 Korea NA KOR-EV71-02 C3 UD
AF302996 1998 China NA SHZH98 C4 UD
AM490154 2005 Vietnam NA 707V/VNM/2005 C4 (4)
AM490163 2005 Vietnam NA 999T/VNM/2005 C5 (4)
AM490153 2005 Vietnam NA 666T/VNM/2005 C5 (4)

*EV, enterovirus; VP, viral protein; HFMD, hand, foot, and mouth disease; NA, not available; UD, unpublished data.

Main Article

References
  1. Brown  BA, Oberste  MS, Alexander  JP Jr, Kennett  ML, Pallansch  MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999;73:9969–75.PubMedGoogle Scholar
  2. McMinn  P, Lindsay  K, Perera  D, Chan  HM, Chan  KP, Cardosa  MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 2001;75:7732–8. DOIPubMedGoogle Scholar
  3. Yan  JJ, Wang  JR, Liu  CC, Yang  HB, Su  IJ. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol. 2000;17:13–22. DOIPubMedGoogle Scholar
  4. Tu  PV, Thao  NT, Perera  D, Huu  TK, Tien  NT, Thuong  TC, Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13:1733–41.PubMedGoogle Scholar
  5. AbuBakar  S, Sam  IC, Yusof  J, Lim  MK, Misbah  S, MatRahim N, et al. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis. 2009;15:79–82. DOIPubMedGoogle Scholar
  6. McMinn  PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91–107. DOIPubMedGoogle Scholar
  7. Oberste  MS, Nix  WA, Maher  K, Pallansch  MA. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol. 2003;26:375–7. DOIPubMedGoogle Scholar
  8. Bible  JM, Iturriza-Gomara  M, Megson  B, Brown  D, Pantelidis  P, Earl  P, Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol. 2008;46:3192–200. DOIPubMedGoogle Scholar
  9. Leitch  EC, Harvala  H, Robertson  I, Ubillos  I, Templeton  K, Simmonds  P. Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. J Clin Virol. 2009;44:119–24. DOIPubMedGoogle Scholar
  10. Witso  E, Palacios  G, Ronningen  KS, Cinek  O, Janowitz  D, Rewers  M, Asymptomatic circulation of HEV71 in Norway. Virus Res. 2007;123:19–29. DOIPubMedGoogle Scholar
  11. Norder  H, Bjerregaard  L, Magnius  L, Lina  B, Aymard  M, Chomel  JJ. Sequencing of 'untypable' enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. J Gen Virol. 2003;84:827–36. DOIPubMedGoogle Scholar
  12. Chang  LY, Lin  TY, Hsu  KH, Huang  YC, Lin  KL, Hsueh  C, Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354:1682–6. DOIPubMedGoogle Scholar
  13. Kao  SJ, Yang  FL, Hsu  YH, Chen  HI. Mechanism of fulminant pulmonary edema caused by enterovirus 71. Clin Infect Dis. 2004;38:1784–8. DOIPubMedGoogle Scholar
  14. Ortner  B, Huang  CW, Schmid  D, Mutz  I, Wewalka  G, Allerberger  F, Epidemiology of enterovirus types causing neurological disease in Austria 1999–2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol. 2009;81:317–24. DOIPubMedGoogle Scholar
  15. Pérez-Vélez  CM, Anderson  MS, Robinson  CC, McFarland  EJ, Nix  WÂA, Pallansch  MA, Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007;45:950–7 . DOIPubMedGoogle Scholar

Main Article

Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external